US Broker Ratings

Orthofix Medical Inc. (OFIX) Stock Analysis: A Look at Its 47% Potential Upside

Orthofix Medical Inc. (NASDAQ: OFIX), a key player in the healthcare sector, operates within the medical devices industry and specializes in innovative solutions for global spine..

HealthStream, Inc. (HSTM) Stock Analysis: Exploring a 48.35% Potential Upside in the Healthcare SaaS Market

For investors seeking opportunities in the healthcare technology sector, HealthStream, Inc. (NASDAQ: HSTM) offers an intriguing prospect. As a leading provider of Software-as-a-Service (SaaS) applications tailored..

Organogenesis Holdings Inc. (ORGO) Stock Analysis: Unveiling a 233% Potential Upside

Organogenesis Holdings Inc. (NASDAQ: ORGO), a pioneering entity in the field of regenerative medicine, offers investors a striking opportunity with a potential upside of 233.33%, according..

SIGA Technologies Inc. (SIGA) Stock Analysis: Evaluating the Undervalued Potential in Healthcare

SIGA Technologies Inc. (SIGA), a key player in the healthcare sector, specifically within the drug manufacturing industry, has carved a niche in the health security market..

Personalis, Inc. (PSNL) Stock Analysis: A 58.95% Potential Upside in Cancer Genomic Testing

Investors eyeing opportunities in the healthcare sector might want to take a closer look at Personalis, Inc. (PSNL), a company making significant strides in the diagnostics..

CorMedix Inc. (CRMD) Stock Analysis: A Biotech Bet with a 131% Upside Potential

CorMedix Inc. (NASDAQ: CRMD), a dynamic player in the biotechnology sector, is piquing investor interest with its promising therapeutic solutions and enticing valuation metrics. With a..

AxoGen, Inc. (AXGN) Stock Analysis: Strong Buy Ratings and a Promising 30% Upside Potential

AxoGen, Inc. (NASDAQ: AXGN) is capturing the attention of investors in the medical devices sector, particularly those looking for opportunities in the innovative field of peripheral..

Cullinan Therapeutics, Inc. (CGEM): Analyst Ratings Signal a 139.71% Potential Upside for Biotechnology Investors

Cullinan Therapeutics, Inc. (NASDAQ: CGEM), a clinical-stage biopharmaceutical company based in Cambridge, Massachusetts, has captured the attention of the investment community with its promising pipeline of..

Cel-Sci Corporation (CVM) Stock Analysis: Unraveling a 583% Potential Upside in Biotech

Cel-Sci Corporation (NASDAQ: CVM) presents a compelling narrative for investors intrigued by the high-risk, high-reward landscape of biotechnology stocks. With an impressive potential upside of 583.06%,..

Iovance Biotherapeutics, Inc. (IOVA) Stock Analysis: A Look at the 132% Potential Upside in Biotech Innovation

For investors eyeing the biotechnology sector, Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) presents a compelling opportunity with its promising potential upside of 132.56%. The company, known for..

Avanos Medical, Inc. (AVNS) Stock Analysis: A Closer Look at Valuation Metrics and Growth Potential in the Healthcare Sector

Avanos Medical, Inc. (NYSE: AVNS) is a prominent player in the healthcare sector, specifically within the medical devices industry. Headquartered in Alpharetta, Georgia, Avanos is known..

Zenas BioPharma, Inc. (ZBIO) Investor Outlook: High Potential Upside of 79.72% in the Biotech Sector

Zenas BioPharma, Inc. (NASDAQ: ZBIO) is capturing the attention of investors with its promising position in the biotechnology industry. With a focus on transformative immunology-based therapies,..

COMPASS Pathways Plc (CMPS) Investor Outlook: Exploring a 282% Potential Upside in the Mental Health Sector

COMPASS Pathways Plc (NASDAQ: CMPS), a pioneering biotechnology company in the mental health space, has been gaining attention for its innovative approach to treating some of..

Upstream Bio, Inc. (UPB) Stock Report: A Biotech Gem with a Potential 471% Upside

Upstream Bio, Inc. (UPB), a promising player in the burgeoning biotechnology sector, is rapidly gaining attention in the healthcare industry. With a market capitalization of $452.84..

Akebia Therapeutics, Inc. (AKBA): Investor Outlook Highlights a 209.86% Potential Upside

Akebia Therapeutics, Inc. (NASDAQ: AKBA), a prominent player in the healthcare sector specializing in biopharmaceuticals, is capturing investor attention with its remarkable potential upside of 209.86%...

Zevra Therapeutics, Inc. (ZVRA)

⚠️ No article content returned.

..

MeiraGTx Holdings plc (MGTX) Stock Analysis: Unveiling a 263.95% Potential Upside in the Burgeoning Gene Therapy Space

Investors looking to capitalize on the growing field of gene therapy may find compelling reasons to consider MeiraGTx Holdings plc (NASDAQ: MGTX). As a clinical-stage genetic..

Butterfly Network, Inc. (BFLY) Stock Analysis: 40% Potential Upside with Cutting-Edge Medical Devices

For investors keen on the healthcare sector, Butterfly Network, Inc. (NASDAQ: BFLY) offers an intriguing opportunity with notable potential upside. This medical device company is at..

Intellia Therapeutics (NTLA) Stock Analysis: Exploring Nearly 92% Upside Potential in Biotech

Intellia Therapeutics, Inc. (NASDAQ: NTLA), a prominent player in the biotechnology sector, is gaining attention for its ambitious foray into gene editing treatments. With the current..

KalVista Pharmaceuticals, Inc. (KALV) Stock Analysis: Biotechnology Innovator with Over 100% Upside Potential

KalVista Pharmaceuticals, Inc. (KALV) is making waves in the biotechnology sector with a robust pipeline aimed at addressing unmet medical needs in hereditary angioedema (HAE). Headquartered..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds